Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors

被引:51
作者
Lane, TA
Ho, AD
Bashey, A
Peterson, S
Young, D
Law, P
机构
[1] Univ Calif San Diego, Sch Med, Dept Pathol, Transfus Serv,Stem Cell Proc Lab, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Blood & Marrow Transplant Program, Stem Cell Lab, La Jolla, CA 92093 USA
关键词
D O I
10.1046/j.1537-2995.1999.39199116893.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: It was previously reported that the combination of granulocyte-macrophage-colony-stimulating factor (GM-CSF) and granulocyte-CSF (G-CSF) for 4 days mobilized more primitive CD34+ subsets than did either G-CSF or GM-CSF atone. STUDY DESIGN AND METHODS: The studies determine the optimal number of days or growth factor dosing for mobilization and collection of peripheral blood progenitor cells, by increasing the days of administration of GM-CSF and/or G-CSF or employing the sequential administration of GM-CSF followed by G-CSF. Sixty normal subjects were given injections of G-CSF or GMCSF alone; GM-CSF and G-CSF concurrently for 4, 5, or 6 days; or a sequential regimen of GM-CSF for 3 or 4 days followed by G-CSF for 2 or 3 days. A 10-L apheresis was performed 24 hours after the last dose. RESULTS: The three most efficacious mobilization regimens consisted of sequential GM-CSF for 3 days followed by G-CSF for either 2 or 3 days and G-CSF alone for 5 days. Each of these regimens resulted in the collection of significantly greater numbers of CD34+ cells by apheresis than any of the 4-day dosing regimens with G-CSF and/or GM-CSF (sequential GM-CSF/G-CSF: 3 days/2 days = 3.58 +/- 0.53 x 10(6) CD34+ cells/kg; GM-CSF/G-CSF: 3 days/3 days = 4.45 +/- 1.08 x 10(6) CD34+ cells/kg; G-CSF: 5 days = 3.58 +/- 0.97 x 10(6) CD34+ cells/kg; all p<0.05 vs. G-CSF and/or GM-CSF for 4 days). Clonogenic assays generally paralleled the level of CD34+ cells. Regimens containing GM-CSF resulted in a higher percentage of the cells from primitive CD34+/CD38-/HLA-DR+ subset than G-CSF alone. CONCLUSION: Compared with 4-day dosing regimens with G-CSF and/or GM-CSF, mobilization of CD34+ cells in normal subjects using sequential GM-CSF for 3 days followed by G-CSF for 2 or 3 days or using G-CSF atone for 5 days increased the number CD34+ cells that can be collected by a single 10-L apheresis 24 hours after the last dose of cytokine.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 42 条
[1]   Duration of filgrastim mobilization and apheresis yield of CD34(+) progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation [J].
Anderlini, P ;
Przepiorka, D ;
Huh, Y ;
Lauppe, J ;
Miller, P ;
Sundberg, J ;
Seong, D ;
Champlin, R ;
Korbling, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) :940-942
[2]   The use of mobilized peripheral blood stem cells from normal donors for allografting [J].
Anderlini, P ;
Korbling, M .
STEM CELLS, 1997, 15 (01) :9-17
[3]   Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures [J].
Anderlini, P ;
Przepiorka, D ;
Seong, D ;
Miller, P ;
Sundberg, J ;
Lichtiger, B ;
Norfleet, F ;
Chan, KW ;
Champlin, R ;
Korbling, M .
TRANSFUSION, 1996, 36 (07) :590-595
[4]  
AUQUIER P, 1995, BONE MARROW TRANSPL, V16, P541
[5]  
Bender J G, 1992, J Hematother, V1, P329, DOI 10.1089/scd.1.1992.1.329
[6]  
BENSINGER W, 1993, BLOOD, V81, P3158
[7]   PERIPHERAL-BLOOD STEM-CELLS (PBSCS) COLLECTED AFTER RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) - AN ANALYSIS OF FACTORS CORRELATING WITH THE TEMPO OF ENGRAFTMENT AFTER TRANSPLANTATION [J].
BENSINGER, WI ;
LONGIN, K ;
APPELBAUM, F ;
ROWLEY, S ;
WEAVER, C ;
LILLEBY, K ;
GOOLEY, T ;
LYNCH, M ;
HIGANO, T ;
KLARNET, J ;
CHAUNCEY, T ;
STORB, R ;
BUCKNER, CD .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :825-831
[8]   TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
BENSINGER, WI ;
WEAVER, CH ;
APPELBAUM, FR ;
ROWLEY, S ;
DEMIRER, T ;
SANDERS, J ;
STORB, R ;
BUCKNER, CD .
BLOOD, 1995, 85 (06) :1655-1658
[9]  
BROWN WB, 1977, STAT BIOMEDICAL INTR, P119
[10]  
Corringham R E, 1995, Blood, V86, P2052